Correlation Between SBI Life and Mangalam Drugs

Can any of the company-specific risk be diversified away by investing in both SBI Life and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SBI Life and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SBI Life Insurance and Mangalam Drugs And, you can compare the effects of market volatilities on SBI Life and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SBI Life with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of SBI Life and Mangalam Drugs.

Diversification Opportunities for SBI Life and Mangalam Drugs

0.1

Correlation Coefficient

SBI Life  Mangalam Drugs

Average diversification

The 3 months correlation between SBI and Mangalam is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding SBI Life Insurance and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and SBI Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SBI Life Insurance are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of SBI Life i.e., SBI Life and Mangalam Drugs go up and down completely randomly.

Pair Corralation between SBI Life and Mangalam Drugs

Assuming the 90 days trading horizon SBI Life Insurance is expected to generate 0.51 times more return on investment than Mangalam Drugs. However, SBI Life Insurance is 1.96 times less risky than Mangalam Drugs. It trades about -0.01 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.11 per unit of risk. If you would invest  146,930  in SBI Life Insurance on October 10, 2024 and sell it today you would lose (615.00) from holding SBI Life Insurance or give up 0.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

SBI Life Insurance  vs.  Mangalam Drugs And

SBI Life Insurance

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SBI Life Insurance has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Mangalam Drugs And

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Mangalam Drugs is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with SBI Life and Mangalam Drugs

The main advantage of trading using opposite SBI Life and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SBI Life position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.

The idea behind SBI Life Insurance and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.